Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three drugs—lidocaine, epinephrine, and morphine—used primarily in regional or local anesthesia for surgical or procedural pain management. Lidocaine is an amide-type local anesthetic that works by blocking sodium channels in neuronal membranes, thereby inhibiting nerve impulse conduction and producing loss of sensation at the site of administration[2][3][4]. Epinephrine acts as a vasoconstrictor via alpha-adrenergic receptor agonism; when combined with lidocaine, it prolongs the duration of anesthesia by reducing systemic absorption and limiting bleeding at the injection site[3][4][7]. Morphine is an opioid analgesic that binds to mu-opioid receptors in the central nervous system to provide potent pain relief[1][8]. The combination may be used for enhanced intraoperative anesthesia and postoperative analgesia, particularly in procedures requiring both profound numbness and extended pain control[9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + epinephrine + morphine.